TCL Archive Clinical Education Grants Held To 170 Payline, No New Awards; Organ Site Renewals Limited To 180 March 26, 1982
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983